BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 29091190)

  • 1. Too much of a good thing: a retrospective study of β-lactam concentration-toxicity relationships.
    Imani S; Buscher H; Marriott D; Gentili S; Sandaradura I
    J Antimicrob Chemother; 2017 Oct; 72(10):2891-2897. PubMed ID: 29091190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insufficient β-lactam concentrations in the early phase of severe sepsis and septic shock.
    Taccone FS; Laterre PF; Dugernier T; Spapen H; Delattre I; Wittebole X; De Backer D; Layeux B; Wallemacq P; Vincent JL; Jacobs F
    Crit Care; 2010; 14(4):R126. PubMed ID: 20594297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An evaluation of risk factors to predict target concentration non-attainment in critically ill patients prior to empiric β-lactam therapy.
    Imani S; Buscher H; Day R; Gentili S; Jones GRD; Marriott D; Norris R; Sandaradura I
    Eur J Clin Microbiol Infect Dis; 2018 Nov; 37(11):2171-2175. PubMed ID: 30120647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case-control study of drug monitoring of β-lactams in obese critically ill patients.
    Hites M; Taccone FS; Wolff F; Cotton F; Beumier M; De Backer D; Roisin S; Lorent S; Surin R; Seyler L; Vincent JL; Jacobs F
    Antimicrob Agents Chemother; 2013 Feb; 57(2):708-15. PubMed ID: 23147743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is high-dose β-lactam therapy associated with excessive drug toxicity in critically ill patients?
    McDonald C; Cotta MO; Little PJ; McWhinney B; Ungerer JP; Lipman J; Roberts JA
    Minerva Anestesiol; 2016 Sep; 82(9):957-65. PubMed ID: 27054905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Considerable variation of trough β-lactam concentrations in older adults hospitalized with infection-a prospective observational study.
    Hatti M; Solomonidi N; Odenholt I; Tham J; Resman F
    Eur J Clin Microbiol Infect Dis; 2018 Mar; 37(3):485-493. PubMed ID: 29380225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic drug monitoring of beta-lactam antibiotics - Influence of sample stability on the analysis of piperacillin, meropenem, ceftazidime and flucloxacillin by HPLC-UV.
    Pinder N; Brenner T; Swoboda S; Weigand MA; Hoppe-Tichy T
    J Pharm Biomed Anal; 2017 Sep; 143():86-93. PubMed ID: 28578254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum β-lactam concentrations in critically ill patients with cirrhosis: a matched case-control study.
    Lheureux O; Trepo E; Hites M; Cotton F; Wolff F; Surin R; Creteur J; Vincent JL; Gustot T; Jacobs F; Taccone FS
    Liver Int; 2016 Jul; 36(7):1002-10. PubMed ID: 26645828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic drug monitoring of β-lactam antibiotics in the critically ill: direct measurement of unbound drug concentrations to achieve appropriate drug exposures.
    Wong G; Briscoe S; McWhinney B; Ally M; Ungerer J; Lipman J; Roberts JA
    J Antimicrob Chemother; 2018 Nov; 73(11):3087-3094. PubMed ID: 30137377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative LC-MS/MS and HPLC-UV Analyses of Meropenem and Piperacillin in Critically Ill Patients.
    Paal M; Heilmann M; Koch S; Bertsch T; Steinmann J; Höhl R; Liebchen U; Schuster C; Kleine FM; Vogeser M
    Clin Lab; 2019 Sep; 65(9):. PubMed ID: 31532096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic drug monitoring of meropenem and piperacillin-tazobactam in the Singapore critically ill population - A prospective, multi-center, observational study (BLAST 1).
    Chua NG; Loo L; Hee DKH; Lim TP; Ng TM; Hoo GSR; Soong JL; Ong JCL; Tang SSL; Zhou YP; Lee W; Lee LS; Cove M; Ling LM; Kwa AL
    J Crit Care; 2022 Apr; 68():107-113. PubMed ID: 34999376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated β-lactam concentrations associated with neurological deterioration in ICU septic patients.
    Beumier M; Casu GS; Hites M; Wolff F; Cotton F; Vincent JL; Jacobs F; Taccone FS
    Minerva Anestesiol; 2015 May; 81(5):497-506. PubMed ID: 25220556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What is the effect of obesity on piperacillin and meropenem trough concentrations in critically ill patients?
    Alobaid AS; Brinkmann A; Frey OR; Roehr AC; Luque S; Grau S; Wong G; Abdul-Aziz MH; Roberts MS; Lipman J; Roberts JA
    J Antimicrob Chemother; 2016 Mar; 71(3):696-702. PubMed ID: 26702922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic drug monitoring of imipenem and the incidence of toxicity and failure in hospitalized patients: a retrospective cohort study.
    Bricheux A; Lenggenhager L; Hughes S; Karmime A; Lescuyer P; Huttner A
    Clin Microbiol Infect; 2019 Mar; 25(3):383.e1-383.e4. PubMed ID: 30528370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. β-lactam antibiotic concentrations during continuous renal replacement therapy.
    Beumier M; Casu GS; Hites M; Seyler L; Cotton F; Vincent JL; Jacobs F; Taccone FS
    Crit Care; 2014 May; 18(3):R105. PubMed ID: 24886826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Standard dosing of piperacillin and meropenem fail to achieve adequate plasma concentrations in ICU patients.
    Petersson J; Giske CG; Eliasson E
    Acta Anaesthesiol Scand; 2016 Nov; 60(10):1425-1436. PubMed ID: 27655029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein binding of β-lactam antibiotics in critically ill patients: can we successfully predict unbound concentrations?
    Wong G; Briscoe S; Adnan S; McWhinney B; Ungerer J; Lipman J; Roberts JA
    Antimicrob Agents Chemother; 2013 Dec; 57(12):6165-70. PubMed ID: 24080664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of β-Lactam Infusion Strategy on Acute Kidney Injury.
    Cotner SE; Rutter WC; Burgess DR; Wallace KL; Martin CA; Burgess DS
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28760891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A microbiological method for determining serum levels of broad spectrum β-lactam antibiotics in critically ill patients.
    Fridlund J; Woksepp H; Schön T
    J Microbiol Methods; 2016 Oct; 129():23-27. PubMed ID: 27469351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ertapenem versus piperacillin/tazobactam for diabetic foot infections in China: a Phase 3, multicentre, randomized, double-blind, active-controlled, non-inferiority trial.
    Xu ZR; Ran XW; Xian Y; Yan XD; Yuan GY; Mu SM; Shen JF; Zhang BS; Gan WJ; Wang J
    J Antimicrob Chemother; 2016 Jun; 71(6):1688-96. PubMed ID: 26888908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.